Academic Fellow Rachel E. Sachs featured in Regulatory Reconnaissance
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. Want to read Recon as soon as it's posted? Follow @Michael_Mezher, @Zachary Brennan and @RAPSorg on Twitter.
In Focus: US
Samsung Targets US Drug Market With Remicade Biosimilar (WSJ-$) (Reuters) (Press)
Republican Senators Lobby FDA Ahead of Decision on Sarepta's DMD Drug (Focus) (STAT)
Our Current Pharmaceutical Payment System Isn't Neutral (Harvard Bill of Health)
Check out Rachel's full post at Petrie-Flom's blog Bill of Health!health care finance health law policy pharmaceuticals rachel sachs regulation